Registration Now Open!
|8:00-8:45||Mary Bove, ND||Restorative Botanical Medicine Gastroenterology - Pt 1||.75|
|8:45-9:30||Mary Bove, ND||Restorative Botanical Medicine Gastroenterology - Pt 2||.75|
|9:30-10:15||Mary Bove, ND||Restorative Botanical Medicine Gastroenterology - Pt 3||.75|
|10:15-11:00||Break and Exhibits|
|11:00-11:45||Michaël Friedman||Neuroprotective Nutrition: Inflammation, Food, and the Brain-gut Axis||.75|
|11:45- 12:30||George Gillson||Hiding in Plain Sight: The Critical Role of the Liver in managing Cortisol||.75|
|2:00- 2:45||Non-CE Class|
|2:45-3:30||Joe Klassen||Hiding in plain sight II: Clinical strategies for improving Gut-HPA axis balance||.75|
|3:30-4:15||Kim Bretz||The Microbiota and Diet - Nutritional Influences||.75|
|4:15-5:00||Break and Exhibits|
|5:00-5:45||Mary Bove, ND||Restorative Botanical Medicine Gastroenterology - Pt 4||.75|
|5:45-6:45||Edward Lichten, MD||Anabolic Steroids and GI Disease||1.0 Pharm Pending|
|1hr||Decker Weiss||Mood, Fatigue, Insomnia: A New Model of Diagnosis and Treatment||1.0|
|1hr||Decker Weiss||Mitochondrial Testing: The Key to Preventing and Reversing Neurological and Cardiovascular Disorders?||1.0|
|1hr||Rachel Carlton Abrams, MD||Using Body Intelligence to Treat Chronic Disease Online Recording||1.0|
|3hr||Christine Salter, MD, DC||Mitochondrial Testing: The Key to Preventing and Reversing Neurological and Cardiovascular Disorders?||3.0|
Restorative Botanical Medicine Gastroenterology
Mary Bove, ND
Dr. Bove will provide a brief overview of gastrointestinal disorders, including inflammatory bowel diseases, gut microbiome, GI infections, SIBO, digestive enzyme deficiency, the gut-brain axis, and constipation. She will provide a review of evidence based herbs for treatment and prevention of the listed gastrointestinal conditions. She will explain the herbal mechanism of action, active constituents, dosage, contraindications, and review of safety issues for each herb. Relevant research studies will be reviewed and critically evaluated. Clinical applications for reviewed herbs will be presented, along with specific lifestyle and diet recommendations which should be implemented.
Goals and Objectives:
· Review clinical conditions including gastrointestinal disorders, including inflammatory bowel diseases, gut microbiome, GI infections, SIBO, digestive enzyme deficiency and constipation.
· Provide a review of herbs known to treat or prevent chronic and acute gastrointestinal conditions.
· Evidence based review of herbal medicine research.
· Evaluate herb safety and drug interaction concerns.
· Herbs reviewed will include (but not limited to): oregano, berberine, garlic, licorice, ginger, bitters, aloe, senna, cascara, peppermint, and lemon balm.
Neuroprotective Nutrition: Inflammation, Food, and the Brain-gut Axis
Michael Friedman, ND
This presentation will review the role of nutrition and inflammation in neuroprotection. There’s a growing literature that demonstrates the direct and indirect role of nutrition on brain health during aging and neurological disease. Many nutrients have direct impact on brain chemicals like brain-derived neurotropic factor. Other nutrients affect microflora, and indirectly influence the brain and nervous system. To make things more complicated, the immune system and immune response to food overlays on the nervous system. This talk reviews the research and case studies that address the role of nutrition and inflammation in the aging brain.
Goals and Objectives:
· Identify nutrients and foods related to neuroprotection based on literature review
· Predict neurological and cognitive symptoms based on immunological profiles
· Outline how the brain and immune system are interconnected
· Summarize evidence-based review of how the immune response to food impacts the brain
The Microbiota and Diet - Nutritional Influences
Kim Bretz, ND
We’ve long known the microbiota is involved with overall health – including digestion, vitamin production, immune and inflammatory modulation – but the strong role of our food affecting the microbiota has been missed in favour of the belief that food itself is the problem. We have focused on the issue of food allergies, intolerances and sensitivities. The diet seems to be narrowed for many patients rather than expanding – a detriment to our microbiota.
While these issues can exist, recent research has shown the need to investigate the bigger role of how our microbiota interacts with our diet and how, in turn, the bacterial metabolites produced affect our health. Microbial imbalances may lead to diseases and the symptoms related to conditions, in association with food, rather than the food itself being the problem.
Discussion in this presentation will include the role of different dietary components in the diet and how they interact with the microbiota, as well as the role and practical use of newer microbiota-focused therapeutic diets. The low FODMAP diet (functional gut disorders), IBD-AID program (Crohn’s disease and ulcerative colitis) and Mediterranean diet will be reviewed.
Goals and Objectives:
· Understand the impact of the diet on the microbiota and how it influences health
· Understand the research in non-absorbable carbohydrates, fibers, phytochemicals and proteins in relation to the microbiota
· Learn about researched diets and their therapeutic effects in health in relation to the microbiota
Hiding in plain sight II: Clinical strategies for improving Gut-HPA axis balance
Joseph Klassen, ND
Dr. Klassen will provide perspective on how gut function ties together different body systems, the endocrine system in particular. The microbiome in its role as the sterolbiome and how this relates to the metabolism of hormones and xenobiotics will be discussed. He will provide strategies for managing enterohepatic circulation and enhancing biliary tree function; an often-forgotten component of the digestive system. Protocols for safely supporting the sluggish and congested liver from a functional approach round out this discussion.
Goals & Objectives:
· Evidence based review of the role of the microbiome and bile acids in steroid hormone homeostasis
· Review factors which damage the microbiome and alter bile acid balance
· Clinical protocols for enhancing liver function and bile acids
· Therapeutic recommendations for improved patient outcomes
· Protocols for improving enterohepatic circulation
Hiding in Plain Sight: The Critical Role of the Liver in managing Cortisol
George Gillson, MD, PhD
Emerging research is identifying the role of liver metabolism in many health concerns where it’s role has not previously been appreciated. Dr. Gillson will describe the fundamental role of liver function in managing cortisol and its various metabolites. Thyroid function, bile acids, environmental toxicity and sex steroid metabolism will be addressed as part of this holistic conversation. He will describe the relevance of understanding the hormone conjugates as a result of liver function and enzyme activity.
Goals & Objectives:
· Develop an appreciation for the networked nature of physiology
· Describe the Gut – HPA axis and implications for steroid hormone balance
· Appreciate that hormones interact with each other
· Discuss role of Bile acids in modulating hormones
· Discuss how this information aids us in our interpretation of laboratory testing.
Anabolic Steroids and GI Disease
Edward Lichten, MD
Crohn's disease and ulcerative colitis, constituents of Inflammatory Bowel Disease, are destructive benign diseases of young adults. Two-hundred thousand young men and women in North America will have major bowel resection annually, half to experience a premature death and many an increased risk of colorectal cancer. New cases in the youngest quadrille are appearing at a 0.5 percent rate per year. Adalimumab, the last pharmaceutical TNF-inhibitor drug approved for IBD was 17 years ago. Adalimumab's failure rate is 40 percent by year two, 60 percent by year five, and the 12-year German study questions whether there is any long-term gain in quality of life at all.
There are now serum hormonal biomarkers that are highly predictive of flairs in Crohn's diseases; the first being the nuclear membrane Estrogen Receptor-beta/Estrogen Receptor-alpha ratio. The second being bioavailable testosterone measured as the Free Androgen Index. Causation is demarcated to hormonal dysregulation at the Hypothalamic-Pituitary-Gonadal Axis suppressing testosterone production. Five inexpensive, generic, FDA approved anabolic steroid medications have been successfully used to treat IBD
After initial medical information intake, measure biomarkers of gonadal hormones, and then treat to normalize these biomarkers. Admixtures of anabolic steroids should reset the biomarkers and reduce the autoimmune, inflammatory, and systemic aspects of disease.
Goals and Objectives:
· Understand evidence based review of Inflammatory Bowel Disease.
· Understand evidence based review of Small Intestinal Bacterial Overgrowth.
· Learn about serum hormonal biomarkers.
· Learn about treatment plans that include the use of anabolic steroids.